Entropy Technologies’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,493
Closed -$900K 1119
2025
Q4
$900K Buy
5,493
+2,710
+97% +$424K 0.05% 412
2025
Q3
$372K Sell
2,783
-7,983
-74% -$970K 0.03% 604
2025
Q2
$1.34M Buy
+10,766
New +$1.37M 0.11% 249
2024
Q4
Sell
-2,500
Closed -$372K 945
2024
Q3
$372K Sell
2,500
-575
-19% -$82.5K 0.04% 509
2024
Q2
$388K Sell
3,075
-399
-11% -$62.5K 0.04% 446
2024
Q1
$639K Sell
3,474
-3,133
-47% -$597K 0.07% 380
2023
Q4
$1.19M Buy
+6,607
New +$1.03M 0.22% 164

Other funds holding RGEN

Entropy Technologies's RGEN Position: Q1 2026 in Review

Entropy Technologies sold out of Repligen (RGEN) in Q1 2026, closing a stake of 5,493 shares — an estimated $900K sold.

Entropy Technologies first reported a position in RGEN in Q4 2023 and held it in 7 quarters. The position peaked at $1.34M in Q2 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Entropy Technologies reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Entropy Technologies sold 5,493 Repligen shares in Q1 2026, an estimated $900K.
  • Entropy Technologies first reported a position in Repligen in Q4 2023 and held it in 7 quarters.
  • Entropy Technologies's Repligen position peaked at $1.34M in Q2 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.